Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CADENCE
NCT04181996Phase 3Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Aug 2020
- Primary completion
- Dec 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in atherosclerosis, sponsored by University of Ottawa Heart Institute. Started Aug 2020; status: completed.
02
Drugs
colchicine
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT04181996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181996.